Larry Mathis Financial Planning’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Larry Mathis Financial Planning's NVS Position: Q3 2026 in Review
Larry Mathis Financial Planning reduced its Novartis (NVS) stake by 8.3% in Q3 2026, selling an estimated $69.2K and leaving 5,054 shares worth $721K. The position accounts for 0.61% of the portfolio, ranked #34.
Larry Mathis Financial Planning first reported a position in NVS in Q4 2025 and has held it in 4 quarters since. The position peaked at $864K in Q2 2026. 1,557 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Larry Mathis Financial Planning held 5,054 shares of Novartis worth $721K as of Q3 2026.
- Larry Mathis Financial Planning sold 456 Novartis shares in Q3 2026, an estimated $69.2K.
- Novartis made up 0.61% of Larry Mathis Financial Planning's portfolio in Q3 2026, its #34 holding.
- Larry Mathis Financial Planning first reported a position in Novartis in Q4 2025 and has held it in 4 quarters since.
- Larry Mathis Financial Planning's Novartis position peaked at $864K in Q2 2026.
- 1,557 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Larry Mathis Financial Planning's 13F filing for Q3 2026, filed 26 Oct 2026.